ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemostatis and Tissue Sealing Agents Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-5R9920
Home | Market Reports | Health| Medical Devices & Equipment
Global Hemostatis and Tissue Sealing Agents Market Insights Forecast to 2028
BUY CHAPTERS

Global Hemostatis and Tissue Sealing Agents Market Research Report 2025

Code: QYRE-Auto-5R9920
Report
September 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
CryoLife
Advance Medical Solution (AMS) Group Plc.
Cohera Medical Inc
Integra Life Sciences Corporation
Pfizer Inc
C R Bard Inc
Cohesion Technologies Inc
HyperBranch Medical Technology
Biomet Inc
Medtronic Inc
B. Braun Medical Inc.
Smith & Nephew

Hemostatis and Tissue Sealing Agents Market Size

The global market for Hemostatis and Tissue Sealing Agents was valued at US$ 3567 million in the year 2024 and is projected to reach a revised size of US$ 5333 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Hemostatis and Tissue Sealing Agents Market

Hemostatis and Tissue Sealing Agents Market

Hemostasis devices and sealants are used to prevent blood loss in various conditions. Their preference over other wound closure methods had led to its increasing use in multiple conditions, especially in endoscopic procedures. From mild injuries to burns and neurosurgical management,all are catered to by the hemostasis and tissue sealing agents market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hemostatis and Tissue Sealing Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatis and Tissue Sealing Agents.
The Hemostatis and Tissue Sealing Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemostatis and Tissue Sealing Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatis and Tissue Sealing Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hemostatis and Tissue Sealing Agents Market Report

Report Metric Details
Report Name Hemostatis and Tissue Sealing Agents Market
Accounted market size in year US$ 3567 million
Forecasted market size in 2031 US$ 5333 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Topical Hemostat
  • Adhesive & Tissue Sealant
Segment by Application
  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, CryoLife Inc., Advance Medical Solution (AMS) Group Plc., Cohera Medical Inc., Integra Life Sciences Corporation, Pfizer Inc., C R Bard Inc., Cohesion Technologies Inc, HyperBranch Medical Technology, Biomet Inc., Medtronic, B Braun Medical Inc., Smith & Nephew
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hemostatis and Tissue Sealing Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hemostatis and Tissue Sealing Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Hemostatis and Tissue Sealing Agents Market growing?

Ans: The Hemostatis and Tissue Sealing Agents Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Hemostatis and Tissue Sealing Agents Market size in 2031?

Ans: The Hemostatis and Tissue Sealing Agents Market size in 2031 will be US$ 5333 million.

Who are the main players in the Hemostatis and Tissue Sealing Agents Market report?

Ans: The main players in the Hemostatis and Tissue Sealing Agents Market are Johnson & Johnson, CryoLife Inc., Advance Medical Solution (AMS) Group Plc., Cohera Medical Inc., Integra Life Sciences Corporation, Pfizer Inc., C R Bard Inc., Cohesion Technologies Inc, HyperBranch Medical Technology, Biomet Inc., Medtronic, B Braun Medical Inc., Smith & Nephew

What are the Application segmentation covered in the Hemostatis and Tissue Sealing Agents Market report?

Ans: The Applications covered in the Hemostatis and Tissue Sealing Agents Market report are Hospitals, Ambulatory Surgical Centers, Home Care Settings, Others

What are the Type segmentation covered in the Hemostatis and Tissue Sealing Agents Market report?

Ans: The Types covered in the Hemostatis and Tissue Sealing Agents Market report are Topical Hemostat, Adhesive & Tissue Sealant

1 Hemostatis and Tissue Sealing Agents Market Overview
1.1 Product Definition
1.2 Hemostatis and Tissue Sealing Agents by Type
1.2.1 Global Hemostatis and Tissue Sealing Agents Market Value Comparison by Type (2024 VS 2031)
1.2.2 Topical Hemostat
1.2.3 Adhesive & Tissue Sealant
1.3 Hemostatis and Tissue Sealing Agents by Application
1.3.1 Global Hemostatis and Tissue Sealing Agents Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Home Care Settings
1.3.5 Others
1.4 Global Hemostatis and Tissue Sealing Agents Market Size Estimates and Forecasts
1.4.1 Global Hemostatis and Tissue Sealing Agents Revenue 2020-2031
1.4.2 Global Hemostatis and Tissue Sealing Agents Sales 2020-2031
1.4.3 Global Hemostatis and Tissue Sealing Agents Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hemostatis and Tissue Sealing Agents Market Competition by Manufacturers
2.1 Global Hemostatis and Tissue Sealing Agents Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hemostatis and Tissue Sealing Agents Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hemostatis and Tissue Sealing Agents, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostatis and Tissue Sealing Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostatis and Tissue Sealing Agents, Product Type & Application
2.7 Global Key Manufacturers of Hemostatis and Tissue Sealing Agents, Date of Enter into This Industry
2.8 Global Hemostatis and Tissue Sealing Agents Market Competitive Situation and Trends
2.8.1 Global Hemostatis and Tissue Sealing Agents Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hemostatis and Tissue Sealing Agents Players Market Share by Revenue
2.8.3 Global Hemostatis and Tissue Sealing Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemostatis and Tissue Sealing Agents Market Scenario by Region
3.1 Global Hemostatis and Tissue Sealing Agents Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hemostatis and Tissue Sealing Agents Sales by Region: 2020-2031
3.2.1 Global Hemostatis and Tissue Sealing Agents Sales by Region: 2020-2025
3.2.2 Global Hemostatis and Tissue Sealing Agents Sales by Region: 2026-2031
3.3 Global Hemostatis and Tissue Sealing Agents Revenue by Region: 2020-2031
3.3.1 Global Hemostatis and Tissue Sealing Agents Revenue by Region: 2020-2025
3.3.2 Global Hemostatis and Tissue Sealing Agents Revenue by Region: 2026-2031
3.4 North America Hemostatis and Tissue Sealing Agents Market Facts & Figures by Country
3.4.1 North America Hemostatis and Tissue Sealing Agents Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hemostatis and Tissue Sealing Agents Sales by Country (2020-2031)
3.4.3 North America Hemostatis and Tissue Sealing Agents Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostatis and Tissue Sealing Agents Market Facts & Figures by Country
3.5.1 Europe Hemostatis and Tissue Sealing Agents Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hemostatis and Tissue Sealing Agents Sales by Country (2020-2031)
3.5.3 Europe Hemostatis and Tissue Sealing Agents Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatis and Tissue Sealing Agents Market Facts & Figures by Region
3.6.1 Asia Pacific Hemostatis and Tissue Sealing Agents Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hemostatis and Tissue Sealing Agents Sales by Region (2020-2031)
3.6.3 Asia Pacific Hemostatis and Tissue Sealing Agents Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hemostatis and Tissue Sealing Agents Market Facts & Figures by Country
3.7.1 Latin America Hemostatis and Tissue Sealing Agents Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hemostatis and Tissue Sealing Agents Sales by Country (2020-2031)
3.7.3 Latin America Hemostatis and Tissue Sealing Agents Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatis and Tissue Sealing Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatis and Tissue Sealing Agents Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hemostatis and Tissue Sealing Agents Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hemostatis and Tissue Sealing Agents Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hemostatis and Tissue Sealing Agents Sales by Type (2020-2031)
4.1.1 Global Hemostatis and Tissue Sealing Agents Sales by Type (2020-2025)
4.1.2 Global Hemostatis and Tissue Sealing Agents Sales by Type (2026-2031)
4.1.3 Global Hemostatis and Tissue Sealing Agents Sales Market Share by Type (2020-2031)
4.2 Global Hemostatis and Tissue Sealing Agents Revenue by Type (2020-2031)
4.2.1 Global Hemostatis and Tissue Sealing Agents Revenue by Type (2020-2025)
4.2.2 Global Hemostatis and Tissue Sealing Agents Revenue by Type (2026-2031)
4.2.3 Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Type (2020-2031)
4.3 Global Hemostatis and Tissue Sealing Agents Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hemostatis and Tissue Sealing Agents Sales by Application (2020-2031)
5.1.1 Global Hemostatis and Tissue Sealing Agents Sales by Application (2020-2025)
5.1.2 Global Hemostatis and Tissue Sealing Agents Sales by Application (2026-2031)
5.1.3 Global Hemostatis and Tissue Sealing Agents Sales Market Share by Application (2020-2031)
5.2 Global Hemostatis and Tissue Sealing Agents Revenue by Application (2020-2031)
5.2.1 Global Hemostatis and Tissue Sealing Agents Revenue by Application (2020-2025)
5.2.2 Global Hemostatis and Tissue Sealing Agents Revenue by Application (2026-2031)
5.2.3 Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Application (2020-2031)
5.3 Global Hemostatis and Tissue Sealing Agents Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Hemostatis and Tissue Sealing Agents Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 CryoLife Inc.
6.2.1 CryoLife Inc. Company Information
6.2.2 CryoLife Inc. Description and Business Overview
6.2.3 CryoLife Inc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CryoLife Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
6.2.5 CryoLife Inc. Recent Developments/Updates
6.3 Advance Medical Solution (AMS) Group Plc.
6.3.1 Advance Medical Solution (AMS) Group Plc. Company Information
6.3.2 Advance Medical Solution (AMS) Group Plc. Description and Business Overview
6.3.3 Advance Medical Solution (AMS) Group Plc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Advance Medical Solution (AMS) Group Plc. Hemostatis and Tissue Sealing Agents Product Portfolio
6.3.5 Advance Medical Solution (AMS) Group Plc. Recent Developments/Updates
6.4 Cohera Medical Inc.
6.4.1 Cohera Medical Inc. Company Information
6.4.2 Cohera Medical Inc. Description and Business Overview
6.4.3 Cohera Medical Inc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cohera Medical Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
6.4.5 Cohera Medical Inc. Recent Developments/Updates
6.5 Integra Life Sciences Corporation
6.5.1 Integra Life Sciences Corporation Company Information
6.5.2 Integra Life Sciences Corporation Description and Business Overview
6.5.3 Integra Life Sciences Corporation Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Integra Life Sciences Corporation Hemostatis and Tissue Sealing Agents Product Portfolio
6.5.5 Integra Life Sciences Corporation Recent Developments/Updates
6.6 Pfizer Inc.
6.6.1 Pfizer Inc. Company Information
6.6.2 Pfizer Inc. Description and Business Overview
6.6.3 Pfizer Inc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
6.6.5 Pfizer Inc. Recent Developments/Updates
6.7 C R Bard Inc.
6.7.1 C R Bard Inc. Company Information
6.7.2 C R Bard Inc. Description and Business Overview
6.7.3 C R Bard Inc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.7.4 C R Bard Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
6.7.5 C R Bard Inc. Recent Developments/Updates
6.8 Cohesion Technologies Inc
6.8.1 Cohesion Technologies Inc Company Information
6.8.2 Cohesion Technologies Inc Description and Business Overview
6.8.3 Cohesion Technologies Inc Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cohesion Technologies Inc Hemostatis and Tissue Sealing Agents Product Portfolio
6.8.5 Cohesion Technologies Inc Recent Developments/Updates
6.9 HyperBranch Medical Technology
6.9.1 HyperBranch Medical Technology Company Information
6.9.2 HyperBranch Medical Technology Description and Business Overview
6.9.3 HyperBranch Medical Technology Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.9.4 HyperBranch Medical Technology Hemostatis and Tissue Sealing Agents Product Portfolio
6.9.5 HyperBranch Medical Technology Recent Developments/Updates
6.10 Biomet Inc.
6.10.1 Biomet Inc. Company Information
6.10.2 Biomet Inc. Description and Business Overview
6.10.3 Biomet Inc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Biomet Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
6.10.5 Biomet Inc. Recent Developments/Updates
6.11 Medtronic
6.11.1 Medtronic Company Information
6.11.2 Medtronic Description and Business Overview
6.11.3 Medtronic Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Medtronic Hemostatis and Tissue Sealing Agents Product Portfolio
6.11.5 Medtronic Recent Developments/Updates
6.12 B Braun Medical Inc.
6.12.1 B Braun Medical Inc. Company Information
6.12.2 B Braun Medical Inc. Description and Business Overview
6.12.3 B Braun Medical Inc. Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.12.4 B Braun Medical Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
6.12.5 B Braun Medical Inc. Recent Developments/Updates
6.13 Smith & Nephew
6.13.1 Smith & Nephew Company Information
6.13.2 Smith & Nephew Description and Business Overview
6.13.3 Smith & Nephew Hemostatis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Smith & Nephew Hemostatis and Tissue Sealing Agents Product Portfolio
6.13.5 Smith & Nephew Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatis and Tissue Sealing Agents Industry Chain Analysis
7.2 Hemostatis and Tissue Sealing Agents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatis and Tissue Sealing Agents Production Mode & Process Analysis
7.4 Hemostatis and Tissue Sealing Agents Sales and Marketing
7.4.1 Hemostatis and Tissue Sealing Agents Sales Channels
7.4.2 Hemostatis and Tissue Sealing Agents Distributors
7.5 Hemostatis and Tissue Sealing Agents Customer Analysis
8 Hemostatis and Tissue Sealing Agents Market Dynamics
8.1 Hemostatis and Tissue Sealing Agents Industry Trends
8.2 Hemostatis and Tissue Sealing Agents Market Drivers
8.3 Hemostatis and Tissue Sealing Agents Market Challenges
8.4 Hemostatis and Tissue Sealing Agents Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
CryoLife
Advance Medical Solution (AMS) Group Plc.
Cohera Medical Inc
Integra Life Sciences Corporation
Pfizer Inc
C R Bard Inc
Cohesion Technologies Inc
HyperBranch Medical Technology
Biomet Inc
Medtronic Inc
B. Braun Medical Inc.
Smith & Nephew
List of Tables
 Table 1. Global Hemostatis and Tissue Sealing Agents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hemostatis and Tissue Sealing Agents Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hemostatis and Tissue Sealing Agents Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hemostatis and Tissue Sealing Agents Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hemostatis and Tissue Sealing Agents Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hemostatis and Tissue Sealing Agents Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hemostatis and Tissue Sealing Agents Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hemostatis and Tissue Sealing Agents, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hemostatis and Tissue Sealing Agents, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hemostatis and Tissue Sealing Agents, Product Type & Application
 Table 12. Global Key Manufacturers of Hemostatis and Tissue Sealing Agents, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hemostatis and Tissue Sealing Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatis and Tissue Sealing Agents as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hemostatis and Tissue Sealing Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hemostatis and Tissue Sealing Agents Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Region (2020-2025)
 Table 19. Global Hemostatis and Tissue Sealing Agents Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Region (2026-2031)
 Table 21. Global Hemostatis and Tissue Sealing Agents Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Region (2020-2025)
 Table 23. Global Hemostatis and Tissue Sealing Agents Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Region (2026-2031)
 Table 25. North America Hemostatis and Tissue Sealing Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hemostatis and Tissue Sealing Agents Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hemostatis and Tissue Sealing Agents Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hemostatis and Tissue Sealing Agents Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hemostatis and Tissue Sealing Agents Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hemostatis and Tissue Sealing Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hemostatis and Tissue Sealing Agents Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hemostatis and Tissue Sealing Agents Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hemostatis and Tissue Sealing Agents Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hemostatis and Tissue Sealing Agents Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hemostatis and Tissue Sealing Agents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hemostatis and Tissue Sealing Agents Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hemostatis and Tissue Sealing Agents Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hemostatis and Tissue Sealing Agents Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hemostatis and Tissue Sealing Agents Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hemostatis and Tissue Sealing Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hemostatis and Tissue Sealing Agents Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hemostatis and Tissue Sealing Agents Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hemostatis and Tissue Sealing Agents Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hemostatis and Tissue Sealing Agents Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hemostatis and Tissue Sealing Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hemostatis and Tissue Sealing Agents Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hemostatis and Tissue Sealing Agents Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hemostatis and Tissue Sealing Agents Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hemostatis and Tissue Sealing Agents Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hemostatis and Tissue Sealing Agents Sales (K Units) by Type (2020-2025)
 Table 51. Global Hemostatis and Tissue Sealing Agents Sales (K Units) by Type (2026-2031)
 Table 52. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Type (2020-2025)
 Table 53. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Type (2026-2031)
 Table 54. Global Hemostatis and Tissue Sealing Agents Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hemostatis and Tissue Sealing Agents Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Type (2020-2025)
 Table 57. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Type (2026-2031)
 Table 58. Global Hemostatis and Tissue Sealing Agents Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Hemostatis and Tissue Sealing Agents Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Hemostatis and Tissue Sealing Agents Sales (K Units) by Application (2020-2025)
 Table 61. Global Hemostatis and Tissue Sealing Agents Sales (K Units) by Application (2026-2031)
 Table 62. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Application (2020-2025)
 Table 63. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Application (2026-2031)
 Table 64. Global Hemostatis and Tissue Sealing Agents Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hemostatis and Tissue Sealing Agents Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Application (2020-2025)
 Table 67. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Application (2026-2031)
 Table 68. Global Hemostatis and Tissue Sealing Agents Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Hemostatis and Tissue Sealing Agents Price (USD/Unit) by Application (2026-2031)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Johnson & Johnson Hemostatis and Tissue Sealing Agents Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. CryoLife Inc. Company Information
 Table 76. CryoLife Inc. Description and Business Overview
 Table 77. CryoLife Inc. Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. CryoLife Inc. Hemostatis and Tissue Sealing Agents Product
 Table 79. CryoLife Inc. Recent Developments/Updates
 Table 80. Advance Medical Solution (AMS) Group Plc. Company Information
 Table 81. Advance Medical Solution (AMS) Group Plc. Description and Business Overview
 Table 82. Advance Medical Solution (AMS) Group Plc. Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Advance Medical Solution (AMS) Group Plc. Hemostatis and Tissue Sealing Agents Product
 Table 84. Advance Medical Solution (AMS) Group Plc. Recent Developments/Updates
 Table 85. Cohera Medical Inc. Company Information
 Table 86. Cohera Medical Inc. Description and Business Overview
 Table 87. Cohera Medical Inc. Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Cohera Medical Inc. Hemostatis and Tissue Sealing Agents Product
 Table 89. Cohera Medical Inc. Recent Developments/Updates
 Table 90. Integra Life Sciences Corporation Company Information
 Table 91. Integra Life Sciences Corporation Description and Business Overview
 Table 92. Integra Life Sciences Corporation Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Integra Life Sciences Corporation Hemostatis and Tissue Sealing Agents Product
 Table 94. Integra Life Sciences Corporation Recent Developments/Updates
 Table 95. Pfizer Inc. Company Information
 Table 96. Pfizer Inc. Description and Business Overview
 Table 97. Pfizer Inc. Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Pfizer Inc. Hemostatis and Tissue Sealing Agents Product
 Table 99. Pfizer Inc. Recent Developments/Updates
 Table 100. C R Bard Inc. Company Information
 Table 101. C R Bard Inc. Description and Business Overview
 Table 102. C R Bard Inc. Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. C R Bard Inc. Hemostatis and Tissue Sealing Agents Product
 Table 104. C R Bard Inc. Recent Developments/Updates
 Table 105. Cohesion Technologies Inc Company Information
 Table 106. Cohesion Technologies Inc Description and Business Overview
 Table 107. Cohesion Technologies Inc Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Cohesion Technologies Inc Hemostatis and Tissue Sealing Agents Product
 Table 109. Cohesion Technologies Inc Recent Developments/Updates
 Table 110. HyperBranch Medical Technology Company Information
 Table 111. HyperBranch Medical Technology Description and Business Overview
 Table 112. HyperBranch Medical Technology Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. HyperBranch Medical Technology Hemostatis and Tissue Sealing Agents Product
 Table 114. HyperBranch Medical Technology Recent Developments/Updates
 Table 115. Biomet Inc. Company Information
 Table 116. Biomet Inc. Description and Business Overview
 Table 117. Biomet Inc. Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Biomet Inc. Hemostatis and Tissue Sealing Agents Product
 Table 119. Biomet Inc. Recent Developments/Updates
 Table 120. Medtronic Company Information
 Table 121. Medtronic Description and Business Overview
 Table 122. Medtronic Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Medtronic Hemostatis and Tissue Sealing Agents Product
 Table 124. Medtronic Recent Developments/Updates
 Table 125. B Braun Medical Inc. Company Information
 Table 126. B Braun Medical Inc. Description and Business Overview
 Table 127. B Braun Medical Inc. Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. B Braun Medical Inc. Hemostatis and Tissue Sealing Agents Product
 Table 129. B Braun Medical Inc. Recent Developments/Updates
 Table 130. Smith & Nephew Company Information
 Table 131. Smith & Nephew Description and Business Overview
 Table 132. Smith & Nephew Hemostatis and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Smith & Nephew Hemostatis and Tissue Sealing Agents Product
 Table 134. Smith & Nephew Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Hemostatis and Tissue Sealing Agents Distributors List
 Table 138. Hemostatis and Tissue Sealing Agents Customers List
 Table 139. Hemostatis and Tissue Sealing Agents Market Trends
 Table 140. Hemostatis and Tissue Sealing Agents Market Drivers
 Table 141. Hemostatis and Tissue Sealing Agents Market Challenges
 Table 142. Hemostatis and Tissue Sealing Agents Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hemostatis and Tissue Sealing Agents
 Figure 2. Global Hemostatis and Tissue Sealing Agents Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hemostatis and Tissue Sealing Agents Market Share by Type: 2024 & 2031
 Figure 4. Topical Hemostat Product Picture
 Figure 5. Adhesive & Tissue Sealant Product Picture
 Figure 6. Global Hemostatis and Tissue Sealing Agents Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hemostatis and Tissue Sealing Agents Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Ambulatory Surgical Centers
 Figure 10. Home Care Settings
 Figure 11. Others
 Figure 12. Global Hemostatis and Tissue Sealing Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Hemostatis and Tissue Sealing Agents Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Hemostatis and Tissue Sealing Agents Sales (2020-2031) & (K Units)
 Figure 15. Global Hemostatis and Tissue Sealing Agents Average Price (USD/Unit) & (2020-2031)
 Figure 16. Hemostatis and Tissue Sealing Agents Report Years Considered
 Figure 17. Hemostatis and Tissue Sealing Agents Sales Share by Manufacturers in 2024
 Figure 18. Global Hemostatis and Tissue Sealing Agents Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Hemostatis and Tissue Sealing Agents Players: Market Share by Revenue in Hemostatis and Tissue Sealing Agents in 2024
 Figure 20. Hemostatis and Tissue Sealing Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Hemostatis and Tissue Sealing Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Hemostatis and Tissue Sealing Agents Sales Market Share by Country (2020-2031)
 Figure 23. North America Hemostatis and Tissue Sealing Agents Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Hemostatis and Tissue Sealing Agents Sales Market Share by Country (2020-2031)
 Figure 27. Europe Hemostatis and Tissue Sealing Agents Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Hemostatis and Tissue Sealing Agents Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Hemostatis and Tissue Sealing Agents Revenue Market Share by Region (2020-2031)
 Figure 35. China Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Hemostatis and Tissue Sealing Agents Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Hemostatis and Tissue Sealing Agents Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Hemostatis and Tissue Sealing Agents Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Hemostatis and Tissue Sealing Agents Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Hemostatis and Tissue Sealing Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Hemostatis and Tissue Sealing Agents by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Hemostatis and Tissue Sealing Agents by Type (2020-2031)
 Figure 57. Global Hemostatis and Tissue Sealing Agents Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Hemostatis and Tissue Sealing Agents by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Hemostatis and Tissue Sealing Agents by Application (2020-2031)
 Figure 60. Global Hemostatis and Tissue Sealing Agents Price (USD/Unit) by Application (2020-2031)
 Figure 61. Hemostatis and Tissue Sealing Agents Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions